- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07257770
Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel
February 12, 2026 updated by: Lo.Li.Pharma s.r.l
Evaluating the Effect of a Medical Device Based on Inositol in Improving Breast Pain
The trial aims to investigate the effect of a topical application of a medical device based on inositol in recovering breast pain
Study Overview
Detailed Description
The present study enrolled patients with breast pain (measured through the VAS) aiming to evaluate the improvement of the pain after the local treatment
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maria Ida Amabile
- Phone Number: +393290847775
- Email: mariaida.amabile@uniroma1.it
Study Locations
-
-
-
Roma, Italy
- Recruiting
- Policlinico Umberto I
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Women aged between 18 and 70 years
- Women who underwent breast surgery at least 15 days prior
- Women experiencing breast pain associated with the surgical wound
Exclusion Criteria:
- Women under the age of 18
- Ongoing systemic and/or local pain therapy
- Pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
No treatment, clinical follow up
|
|
|
Experimental: treatment inositol
daily administration of the gel
|
Topical application of a medical device based on inositol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of breast pain
Time Frame: 3 months
|
Breast pain is evaluated by using VAS (Visual Analogue Scale)
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Follow up breast pain
Time Frame: 6 months
|
Breast pain is evaluated by using VAS (Visual Analogue Scale)
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 11, 2025
Primary Completion (Estimated)
April 11, 2026
Study Completion (Estimated)
July 11, 2026
Study Registration Dates
First Submitted
November 19, 2025
First Submitted That Met QC Criteria
November 27, 2025
First Posted (Actual)
December 2, 2025
Study Record Updates
Last Update Posted (Actual)
February 13, 2026
Last Update Submitted That Met QC Criteria
February 12, 2026
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- INO-BREAST
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mastalgia
-
ASCEND TherapeuticsCompletedCyclic Breast Pain, Cyclic Mastalgia
-
FemmePharma Global Healthcare, Inc.CompletedModerate to Severe Cyclic MastalgiaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Satakunta Central HospitalTampere UniversityCompleted
-
Royal Marsden NHS Foundation TrustUnknownMastalgia | Breast PainUnited Kingdom
-
Pinggu Hospital of Beijing Traditional Chinese...Pinggu huangsongyu Community hospital; Pinggu Xiagezhuang Community hospitalRecruiting
-
New York Institute of TechnologyWithdrawn
-
Sisli Hamidiye Etfal Training and Research HospitalCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
Clinical Trials on inositol
-
Mst.Sumyara KhatunBangladesh Medical UniversityCompletedPCOS (Polycystic Ovary Syndrome)Bangladesh
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedRetinopathy of Prematurity | Bronchopulmonary Dysplasia (BPD) | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
G. d'Annunzio UniversityUniversity of ChietiUnknown
-
Università degli Studi 'G. d'Annunzio' Chieti e...Unknown
-
Postgraduate Institute of Dental Sciences RohtakUnknownPolycystic Ovary Syndrome | Periodontitis | Insulin Resistance
-
Cardarelli HospitalNot yet recruiting
-
Lo.Li.Pharma s.r.lCompletedPolycystic Ovarian Syndrome (PCOS)Italy
-
Lo.Li.Pharma s.r.lCompleted
-
AGUNCO Obstetrics and Gynecology CentreSan Raffaele University Hospital, Italy; Research Center for Reproductive Medicine...Completed
-
Muhammad Aamir LatifCompletedPolycystic Ovarian SyndromePakistan